Platelet endothelial aggregation receptor 1 (PEAR1) rs12041331 has been recently associated with aspirin-alone or dual antiplatelet therapy (DAPT) response, although the association between rs12041331 and stroke outcome is not fully determined (9–12). Here, PEAR1 is linked to stroke disorder.